COVID-19 Therapeutics Reporting Reminder

Oregon Department of Human Services sent this bulletin at 11/03/2022 04:06 PM PDT

Thank you for your role in supporting access to therapeutics in Oregon. The Oregon Health Authority (OHA) appreciates your partnership as we continue navigating the federal allocation process.

Therapeutics Inventory and Utilization Reminder

Inventory & utilization reporting supports visibility on where therapeutics are throughout Oregon. Therefore, it is crucial that each site report their inventory & utilization of Evusheld, Paxlovid, and Lagevrio twice a week on Mondays and Thursdays, by 11:59pm, including any product redistributed to other sites.

If your site has received OHA allocated Bebtelovimab, please continue to report inventory and utilization in HPOP. Please do not report commercially purchased Bebtelovimab in HPOP.

How to report inventory and utilization:

To report utilization, please login to HPoP.
For assistance with basic HPoP processes please see our Provider Operations Manual (sections 3-5).

Please visit our COVID-19 Therapeutics Landing Page for information and resources on mAbs and antivirals.

For all questions or inquiries, please email us at OHA.Therapeutics@odhsoha.oregon.gov.

We thank you for your understanding.

Manage Account Preferences Unsubscribe Contact	Let's be friends